Musings from The Power List: Michael May
September 22, 2026
CCRM CEO Michael May on quantum computing, commercialization, and the next era of cell therapy
5 min read
False
Advertisement
Technology & Manufacturing
Roving Reporter Asks: How Is Cell and Gene Therapy Manufacturing Becoming More Scalable?
September 18, 2026
IBTV speaks with industry leaders at ASGCT 2026 about the technologies, processes, and manufacturing strategies helping advanced therapies progress toward commercial scale
1 min read
The GLP-1 Capacity Squeeze
By Tommy Schornak
September 16, 2026
As demand for GLP-1 medicines grows, injectable manufacturers must increase output without compromising quality or squeezing supply for other therapies
4 min read
What Do Scientists Want from AI?
September 14, 2026
Scientists are already using AI in the lab – but many are doing so without the safeguards their employers may assume are in place
5 min read
The Manufacturing Questions Facing Chinese Biotech
September 9, 2026
Lonza’s Wayne Wen discusses the growing maturity of China’s drug development and manufacturing ecosystem – and what companies need to compete internationally
5 min read
Manufacturing Reality Behind Personalized Cancer Vaccines
By Amy Walker
September 7, 2026
As personalized cancer vaccines move closer to commercialization, manufacturers must rethink DNA production to deliver batch-for-one treatments with the required speed, consistency, and quality
3 min read
Breaking Manufacturing Bottlenecks in Nucleic Acid Therapeutics
By David Butler
August 31, 2026
New approaches to oligonucleotide production, mRNA design, and supply chain control could help turn promising nucleic acid therapies into scalable commercial products
4 min read
The Hidden Complexity of Stability Storage
By Lori A. Ball
August 27, 2026
Why preserving samples is a scientific, regulatory, and operational challenge – and what’s at risk when it goes wrong
9 min read
The Biggest Bottlenecks Holding Back Cell and Gene Therapy
August 24, 2026
Members of the 2026 Power List argue that manufacturing, infrastructure, reimbursement, and investment now pose the greatest challenges
9 min read
The Road to Commercial-Scale iPSC Cell Therapy
August 19, 2026
Can iPSC platforms deliver consistent, commercial-scale cell therapies for large patient populations?
5 min read
